Division of Colon and Rectal Surgery, St Joseph Mercy Hospital Ann Arbor, Ann Arbor, MI, USA.
Section of Colon and Rectal Surgery, Stanford University Medical Center, Stanford, CA, USA.
Ann Surg Oncol. 2018 Nov;25(12):3587-3595. doi: 10.1245/s10434-018-6740-y. Epub 2018 Sep 5.
Compared with open surgery, minimally invasive surgery for colon cancer has been shown to improve short-term outcomes and yield equivalent long-term oncologic results. It remains to be seen if oncologic outcomes for the minimally invasive approach for rectal cancer are equivalent to traditional open rectal resection.
We conducted a systematic review of Medline, SCOPUS, and Cochrane databases. Relevant studies were selected using Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Five key questions comparing minimally invasive and open oncologic outcomes for rectal cancer were specifically analyzed. A meta-analysis was not done due to heterogeneity of studies.
Forty-five studies met inclusion criteria, including six randomized controlled trials. The laparoscopic approach to rectal resection was not more likely than the traditional open approach to have clear circumferential and distal margins, a complete total mesorectal excision grade, ≥ 12 lymph nodes in the resected specimen, reduced local recurrence rates, or reduced overall survival rates. Two randomized trials revealed that successful laparoscopic resection was not noninferior to open.
Caution should be exercised when choosing surgical options for rectal cancer. Results of randomized trials could not prove that short-term oncologic outcomes of laparoscopic surgery were equivalent to those after open surgery even when performed by surgeons with laparoscopic expertise. However, reported long-term data have not shown a difference in outcomes between laparoscopic and open surgery. Future advances in minimally invasive technology may improve oncologic margins but these will require careful study and scrutiny.
与开放手术相比,结肠癌的微创手术已被证明可以改善短期结果,并获得等效的长期肿瘤学结果。对于直肠癌的微创方法的肿瘤学结果是否与传统的开放性直肠切除术相当,仍有待观察。
我们对 Medline、SCOPUS 和 Cochrane 数据库进行了系统评价。使用系统评价和荟萃分析的首选报告项目(PRISMA)指南选择相关研究。专门分析了比较直肠癌微创和开放肿瘤学结果的五个关键问题。由于研究的异质性,未进行荟萃分析。
45 项研究符合纳入标准,包括 6 项随机对照试验。腹腔镜直肠切除术与传统的开放性方法相比,不太可能有清晰的环周和远端边缘、完整的全直肠系膜切除分级、切除标本中≥12 个淋巴结、降低局部复发率或降低总生存率。两项随机试验表明,成功的腹腔镜切除并不优于开放性。
在选择直肠癌的手术方案时应谨慎。随机试验的结果不能证明腹腔镜手术的短期肿瘤学结果与开放性手术相当,即使由具有腹腔镜专业知识的外科医生进行手术也是如此。然而,报告的长期数据并未显示腹腔镜手术和开放性手术之间的结果存在差异。微创技术的未来进步可能会改善肿瘤学边缘,但这些需要仔细研究和审查。